Atypical onset of obsessive‐compulsive disorder at age 50 following post‐SARS‐COV‐2 syndrome: A case report

This case illustrates the atypical onset of OCD in an older adult following SARS-COV-2 infection, potentially driven by neuroinflammation and altered neural pathways. The partial response to fluvoxamine and the need for risperidone suggest that SARS-COV-2-related OCD may involve complex neuroimmune changes beyond serotonin dysregulation. This case emphasizes the importance of recognizing neuropsychiatric complications in SARS-COV-2 survivors and underscores the need for further research into the mechanisms and management of SARS-COV-2-related neuropsychiatric symptoms, including OCD.